Compare CSW & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSW | OPCH |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.9B |
| IPO Year | N/A | 1996 |
| Metric | CSW | OPCH |
|---|---|---|
| Price | $279.50 | $30.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $321.40 | $37.44 |
| AVG Volume (30 Days) | 135.6K | ★ 1.7M |
| Earning Date | 01-01-0001 | 05-22-2026 |
| Dividend Yield | ★ 0.39% | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | N/A | ★ 1.27 |
| Revenue | N/A | ★ $4,998,202,000.00 |
| Revenue This Year | $23.19 | $7.53 |
| Revenue Next Year | $16.82 | $8.58 |
| P/E Ratio | $40.25 | ★ $24.55 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $230.45 | $24.24 |
| 52 Week High | $337.02 | $36.80 |
| Indicator | CSW | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 39.65 | 32.84 |
| Support Level | $238.43 | $27.04 |
| Resistance Level | $281.14 | $31.14 |
| Average True Range (ATR) | 12.52 | 1.20 |
| MACD | -2.49 | -0.51 |
| Stochastic Oscillator | 4.78 | 18.46 |
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.